Clinical trials
Cardiomyopathy, Hypertrophic trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 2 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 3 |
| Completed | 3 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 3 |
| Atridia Pty Ltd. | 1 |
| Cytokinetics | 1 |
| Flinders University | 1 |
| Gilead Sciences | 1 |
| Pfizer | 1 |
| Western Sydney Local Health District | 1 |
| Yale University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathy, Hypertrophic | 10 |
| Cardiomyopathies | 2 |
| Heart Failure | 2 |
| Hypertrophy | 2 |
| Angina Pectoris | 1 |
| Cardiomyopathy, Dilated | 1 |
| Cardiomyopathy, Hypertrophic, Familial | 1 |
| Dyspnea | 1 |
| Long QT Syndrome | 1 |
| Sarcoidosis | 1 |
Trials
Showing 51 to 10 of 10. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.